Flightpath Biosciences (Drug Discovery)

2600 Tenth Street Ste. 435


Developer of biotechnology designed to create new therapies to treat Lyme disease. The company develops novel therapeutics and narrow-spectrum for the treatment of tick-borne diseases offers to advance microbiome-targeted therapeutics and diagnostics for the treatment of rare infectious diseases, enabling patients to get a new form of treatment with no side effects.